Sacha LOISEAU

Sacha founded Mauna Kea Technologies in May 2000 and has been its CEO ever since. A co-inventor of the probe-based Confocal Laser Endomicroscopy technology, he piloted the development of the Cellvizio product line, raising over € 110m with private and public investors, including €56.5m through a July 2011 IPO on the NYSE Euronext Paris stock exchange, the largest healthcare IPO in Europe that year.
In 2013, Sacha was named the co-lead of France’s Re-industrialization Plan for Medical Devices by the French President and then a member of the Committee for the Future of Medicine. Sacha sits on the Post-Planning Board at Ecole Polytechnique and has served as a mentor of the Polytechnique-Stanford Ignite Program for young MedTech entrepreneurs for several years. Sacha was instrumenta is a former board member of Sinequa, a leading enterprise search company.
Sacha started his career at the National Center for Space Studies (CNES) in Toulouse and at the Paris Observatory, then joined NASA’s Jet Propulsion Laboratory (JPL) in Pasadena, California, as a research scientist. Sacha is a graduate of the École Polytechnique in Paris and has a Ph.D. in Astrophysics and Optical Instrumentation. Sacha is the author of multiple scientific articles and holds 7 international patents.